Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD P 506 A photodynamic therapy for distal subungual onychomycosis of the great toenail
2014-001493-34Phase 2Completed
- Sponsor
- photonamic GmbH & Co. KG
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in onychomycosis, sponsored by photonamic GmbH & Co. KG. Primary endpoints: Clinically Complete Cure at 12 months and Mycological efficacy at 12 months. Started Oct 2014; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
onychomycosis
Beyond the preview
Go deeper on 2014-001493-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001493-34.